◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

AGIOS PHARMACEUTICALS, INC.

AGIOS PHARMACEUTICALS, INC.
CAMBRIDGE, MA
Loading...
Price History
Market Data
Market Cap1.60B
P/E Ratio-
P/B Ratio1.34
EPS-7.11
Dividend Yield-
D/E Ratio0.09
Current Ratio11.46
CurrencyUSD
Key Financial Metrics
54.03M
Revenue
-412.78M
Net Income
-7.11
EPS (Diluted)
-679.80M
Free Cash Flow
Profitability
Gross Margin 88.3%
Operating Margin -873.9%
Net Profit Margin -764.0%
EBITDA -472.13M
Returns & Efficiency
Return on Assets (ROA) -31.8%
Return on Equity (ROE) -34.6%
Dividend Yield -
EPS -7.11
Financial Health
Total Assets 1.30B
Total Debt -
Debt to Equity 0.09x
Current Ratio 11.46
Insider Trading Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report

Loading...

10-Q
Quarterly Report

Loading...

8-K
Recent News

Loading...

Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
IndustryChemicals & Allied Products
HQCAMBRIDGE, MA
Fiscal Year2025
Peers
931.26B
P/E: --
931.26B
P/E: --
543.83B
P/E: --
365.53B
P/E: --
306.50B
P/E: 632.4
306.50B
P/E: 632.4
281.00B
P/E: --
281.00B
P/E: --
Financial Statistics
Valuation
Market Cap$1.60B
P/E Ratio (TTM)-
Price to Book1.34
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin88.3%
Operating Margin-873.9%
Net Margin-764.0%
ROE-34.6%
ROA-31.8%
Leverage & Liquidity
Debt to Equity0.09
Current Ratio11.46
Total Debt-
Total Assets$1.30B
Stockholders' Equity$1.19B
Income Statement (FY 2025)
Revenue$54.03M
Gross Profit$47.68M
Operating Income$-472.13M
Net Income$-412.78M
EPS (Diluted)$-7.11
Cash Flow (FY 2025)
Free Cash Flow$-679.80M
Cash & Equivalents$89.13M
Revenue Growth48.0%
SEC Filings by Category
Insider Trading Activity
Neutral 0 Buys $0 0 Sales $0 0 Exercises $0 Net: $0
InsiderTitleDateTypeSharesPriceValue
Company Information
Business Address88 SIDNEY STREET
CAMBRIDGE, MA 02139
Phone617-649-8600
IncorporatedDE, US
EIN000000000
Fiscal Year End1231
Shares Outstanding58.59M
Stockholders' Equity$1.19B
Cash & Equivalents$89.13M
Recent Filings View All
8-K Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-29
Local
SCHEDULE 13G Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
10-Q Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-04-29
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-06
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-06
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-06
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-06
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-06
Local
4 Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-06
Local
144 Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-02
Local
144 Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-02
Local
144 Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-02
Local
144 Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-02
Local
144 Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-02
Local
144 Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-02
Local
Loading...

Loading management data...

Loading...

Loading board of directors...

Loading...

Loading institutional holders...

Loading...

Loading short interest data...

Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
Company NameAGIOS PHARMACEUTICALS, INC.
TickerAGIO
Exchange--
SectorManufacturing
IndustryChemicals & Allied Products
HeadquartersCAMBRIDGE, MA
Fiscal Year2025
Financial Summary
Market Cap1.60B
Revenue54.03M
Net Income-412.78M
P/E Ratio-
EPS-7.11
Net Margin-764.0%
ROE-34.6%
Dividend Yield-
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...